Citadel Advisors’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 6654 |
|
|
2025
Q1 | – | Sell |
-8,692
| Closed | -$16.4K | – | 6671 |
|
|
2024
Q4 | $16.4K | Buy |
+8,692
| New | +$16.4K | ﹤0.01% | 5673 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6439 |
|
|
2023
Q4 | – | Sell |
-676
| Closed | -$2.99K | – | 6448 |
|
|
2023
Q3 | $2.99K | Buy |
+676
| New | +$2.99K | ﹤0.01% | 5586 |
|
|
2023
Q2 | – | Sell |
-4,533
| Closed | -$98.8K | – | 6280 |
|
|
2023
Q1 | $98.8K | Buy |
4,533
+2,472
| +120% | +$53.9K | ﹤0.01% | 4913 |
|
|
2022
Q4 | $44.5K | Buy |
2,061
+421
| +26% | +$9.1K | ﹤0.01% | 5314 |
|
|
2022
Q3 | $40K | Buy |
1,640
+1,112
| +211% | +$27.1K | ﹤0.01% | 5381 |
|
|
2022
Q2 | $11K | Sell |
528
-3,196
| -86% | -$66.6K | ﹤0.01% | 5806 |
|
|
2022
Q1 | $133K | Sell |
3,724
-165
| -4% | -$5.89K | ﹤0.01% | 5509 |
|
|
2021
Q4 | $106K | Sell |
3,889
-2,336
| -38% | -$63.7K | ﹤0.01% | 5871 |
|
|
2021
Q3 | $270K | Buy |
6,225
+2,408
| +63% | +$104K | ﹤0.01% | 5113 |
|
|
2021
Q2 | $191K | Sell |
3,817
-5,001
| -57% | -$250K | ﹤0.01% | 5608 |
|
|
2021
Q1 | $397K | Buy |
8,818
+4,447
| +102% | +$200K | ﹤0.01% | 4773 |
|
|
2020
Q4 | $114K | Buy |
+4,371
| New | +$114K | ﹤0.01% | 4660 |
|
|
2018
Q1 | – | Sell |
-154
| Closed | -$32K | – | 4286 |
|
|
2017
Q4 | $32K | Buy |
+154
| New | +$32K | ﹤0.01% | 3713 |
|